Sri Devineni
About Sri Devineni
Sri Devineni serves as the Associate Director of Medical Safety Operations at Mirum Pharmaceuticals, Inc., bringing over ten years of experience in drug safety operations. He has authored various aggregate reports and has held multiple roles in pharmacovigilance across several companies, including CTI BioPharma and HETERO USA INC.
Work at Mirum Pharmaceuticals
Sri Devineni serves as the Associate Director of Medical Safety Operations at Mirum Pharmaceuticals, Inc. since 2022. In this role, he is responsible for overseeing medical safety operations, ensuring compliance with regulatory requirements, and managing adverse event reporting. His position involves collaboration with various teams to enhance drug safety protocols and improve patient outcomes.
Previous Experience in Drug Safety
Sri Devineni has over ten years of experience in drug safety operations. He has held multiple positions in various organizations, including roles as Drug Safety Manager and Sr Drug Safety Specialist at CTI BioPharma from 2016 to 2021. His earlier experience includes working as a Pharmacovigilance Scientist at HETERO USA INC and as a Drug Safety Specialist at Aurobindo Pharma. His expertise includes oversight of CROs and managing adverse events.
Education and Expertise
Sri Devineni holds a Bachelor’s Degree in Pharmacy, which he obtained from 2003 to 2007. He further pursued a Master’s Degree in Pharmacology and Toxicology from 2008 to 2010. His educational background provides a strong foundation for his extensive experience in pharmacovigilance and drug safety operations.
Skills in Pharmacovigilance
Sri Devineni possesses expertise in managing EudraVigilance accounts, a system for analyzing suspected adverse reactions to medicines in Europe. He has experience with various safety and clinical databases, including ArisG, Argus, Empirica Trace, and EDC. His work includes generating descriptive patient narratives and ensuring quality control in pharmacovigilance processes.
Career Timeline
Sri Devineni's career includes significant roles in the pharmaceutical industry. He worked at Genentech as a Clinical Safety Specialist from 2013 to 2014 and held a position at MannKind Corporation as Sr Manager Pharmacovigilance for eight months in 2021-2022. His career reflects a consistent focus on drug safety and pharmacovigilance across various organizations.